AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer
businesswire.com
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in